Market Cap 506.25M
Revenue (ttm) 9.68M
Net Income (ttm) -244.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 15.44
Profit Margin -2,521.59%
Debt to Equity Ratio 0.00
Volume 177,006
Avg Vol 512,548
Day's Range N/A - N/A
Shares Out 52.35M
Stochastic %K 6%
Beta -0.23
Analysts Sell
Price Target $21.20

Company Profile

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of tr...

Industry: Biotechnology
Sector: Healthcare
Phone: 353 1 236 2500
Fax: 353 1 902 3510
Address:
77 Sir John Rogerson’s Quay, Block C Grand Canal Docklands, Dublin, Ireland
takingstock73
takingstock73 May. 11 at 4:14 PM
$PRTA any rumor why this is dipping ?
3 · Reply
tumanako
tumanako May. 8 at 11:06 AM
$PRTA Institutional accumulations
0 · Reply
buyandsold
buyandsold May. 5 at 6:14 PM
$PRTA The share count was approximately 53.8 million ordinary shares as of February 12, 2026 (just before the buyback was announced on February 27), and the proxy statement filed in late March 2026 still showed 53,832,982 shares outstanding as of the March 2, 2026 record date. That's essentially no change over a period when buybacks would have started showing up if they were buying aggressively.
0 · Reply
French_Vibe
French_Vibe Apr. 27 at 8:12 PM
$PRTA $NVO https://ir.prothena.com/investors/press-releases/news-details/2026/Prothena-Announces-Novo-Nordisk-Obtains-Fast-Track-Designation-from-the-U-S--FDA-for-Coramitug-PRX004-in-ATTR-Amyloidosis-with-Cardiomyopathy/default.aspx
0 · Reply
Sambong
Sambong Apr. 23 at 4:28 PM
$PRTA 🤔🤔👀👀
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 17 at 2:03 PM
$PRTA RSI: 73.93, MACD: 0.3955 Vol: 0.71, MA20: 9.92, MA50: 9.42 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Sambong
Sambong Apr. 14 at 3:23 PM
$PRTA 20 seems likely
1 · Reply
buyandsold
buyandsold Apr. 11 at 2:58 PM
$PRTA just announced investment to "further elucidate the potential of our preclinical programs and CYTOPE® technology." Setting our dollars alight. I may exit in disgust.
0 · Reply
Doozio
Doozio Apr. 8 at 5:20 AM
$PRTA chop chop huckleberries let’s go rockin up da Roger ONTO 🐒🍌🧠⏰♾️
0 · Reply
buyandsold
buyandsold Mar. 25 at 8:07 PM
$PRTA they better be in buyback Xtreme mode at this discounr or Im gonna lose it
0 · Reply
Latest News on PRTA
Prothena price target raised to $20 from $19 at Citizens

2026-05-08T10:14:04.000Z - 5 days ago

Prothena price target raised to $20 from $19 at Citizens


Prothena names Annie Kingston as Chief Strategy Officer

2026-04-10T20:10:31.000Z - 4 weeks ago

Prothena names Annie Kingston as Chief Strategy Officer


Prothena Announces Leadership Team Updates

Apr 10, 2026, 4:05 PM EDT - 4 weeks ago

Prothena Announces Leadership Team Updates


Prothena announces $100M share repurchase plan

2026-02-27T21:20:51.000Z - 2 months ago

Prothena announces $100M share repurchase plan


Prothena expects to end year with $255M in cash, equivalents

2026-02-27T21:20:25.000Z - 2 months ago

Prothena expects to end year with $255M in cash, equivalents

BMY NVO


Prothena Announces up to $100 Million Share Repurchase Plan

Feb 27, 2026, 4:15 PM EST - 2 months ago

Prothena Announces up to $100 Million Share Repurchase Plan


Prothena Corporation Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:30 PM EST - 2 months ago

Prothena Corporation Earnings Call Transcript: Q4 2025


Prothena Announces Board of Directors Update

Dec 12, 2025, 4:05 PM EST - 5 months ago

Prothena Announces Board of Directors Update


Prothena price target raised to $19 from $11 at Citizens JMP

2025-12-01T10:40:23.000Z - 5 months ago

Prothena price target raised to $19 from $11 at Citizens JMP


Prothena price target raised to $8 from $4 at BofA

2025-11-24T14:16:05.000Z - 6 months ago

Prothena price target raised to $8 from $4 at BofA

NVO


Prothena announces poster presentation on TDP-43 CYTOPE program

2025-11-19T21:10:54.000Z - 6 months ago

Prothena announces poster presentation on TDP-43 CYTOPE program


Prothena price target raised to $30 from $20 at H.C. Wainwright

2025-11-07T14:26:08.000Z - 6 months ago

Prothena price target raised to $30 from $20 at H.C. Wainwright


Prothena price target raised to $36 from $15 at Piper Sandler

2025-10-28T10:41:09.000Z - 7 months ago

Prothena price target raised to $36 from $15 at Piper Sandler


Prothena price target raised to $20 from $14 at H.C. Wainwright

2025-10-07T12:35:38.000Z - 7 months ago

Prothena price target raised to $20 from $14 at H.C. Wainwright


Prothena price target lowered to $11 from $29 at Citizens JMP

2025-09-02T10:40:29.000Z - 9 months ago

Prothena price target lowered to $11 from $29 at Citizens JMP


Prothena price target lowered to $15 from $81 at Piper Sandler

2025-08-28T10:35:11.000Z - 9 months ago

Prothena price target lowered to $15 from $81 at Piper Sandler


Prothena Announces Corporate Restructuring

Jun 18, 2025, 4:05 PM EDT - 11 months ago

Prothena Announces Corporate Restructuring


Prothena Corporation Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Prothena Corporation Earnings Call Transcript: Q4 2024


Prothena to Participate in Upcoming Healthcare Conferences

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Prothena to Participate in Upcoming Healthcare Conferences


Prothena Corporation Earnings Call Transcript: Q4 2023

Feb 15, 2024, 4:30 PM EST - 2 years ago

Prothena Corporation Earnings Call Transcript: Q4 2023


Prothena prepares for potential sale - Bloomberg News

Oct 16, 2023, 11:57 AM EDT - 2 years ago

Prothena prepares for potential sale - Bloomberg News


takingstock73
takingstock73 May. 11 at 4:14 PM
$PRTA any rumor why this is dipping ?
3 · Reply
tumanako
tumanako May. 8 at 11:06 AM
$PRTA Institutional accumulations
0 · Reply
buyandsold
buyandsold May. 5 at 6:14 PM
$PRTA The share count was approximately 53.8 million ordinary shares as of February 12, 2026 (just before the buyback was announced on February 27), and the proxy statement filed in late March 2026 still showed 53,832,982 shares outstanding as of the March 2, 2026 record date. That's essentially no change over a period when buybacks would have started showing up if they were buying aggressively.
0 · Reply
French_Vibe
French_Vibe Apr. 27 at 8:12 PM
$PRTA $NVO https://ir.prothena.com/investors/press-releases/news-details/2026/Prothena-Announces-Novo-Nordisk-Obtains-Fast-Track-Designation-from-the-U-S--FDA-for-Coramitug-PRX004-in-ATTR-Amyloidosis-with-Cardiomyopathy/default.aspx
0 · Reply
Sambong
Sambong Apr. 23 at 4:28 PM
$PRTA 🤔🤔👀👀
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 17 at 2:03 PM
$PRTA RSI: 73.93, MACD: 0.3955 Vol: 0.71, MA20: 9.92, MA50: 9.42 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Sambong
Sambong Apr. 14 at 3:23 PM
$PRTA 20 seems likely
1 · Reply
buyandsold
buyandsold Apr. 11 at 2:58 PM
$PRTA just announced investment to "further elucidate the potential of our preclinical programs and CYTOPE® technology." Setting our dollars alight. I may exit in disgust.
0 · Reply
Doozio
Doozio Apr. 8 at 5:20 AM
$PRTA chop chop huckleberries let’s go rockin up da Roger ONTO 🐒🍌🧠⏰♾️
0 · Reply
buyandsold
buyandsold Mar. 25 at 8:07 PM
$PRTA they better be in buyback Xtreme mode at this discounr or Im gonna lose it
0 · Reply
Quantumup
Quantumup Mar. 25 at 2:15 PM
Morgan Stanley🏁 $IMMX Overweight; $20 $PRTA $AZN ABBV GSK JNJ - LEGN Citizens (A/O 3/9)🏁Market Outperform; $23 Here's what Morgan Stanley and Citizens said in their initiation reports: https://x.com/Quantumup1/status/2036808396326805561?s=20
0 · Reply
buyandsold
buyandsold Mar. 24 at 8:07 PM
$PRTA how this is not $12 i have no concept. Will they ever use the buyback. Restricted is a fantasy
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 24 at 1:52 AM
$PRTA Share Price: $8.81 Contract Selected: Sep 18, 2026 $10 Calls Buy Zone: $0.72 – $0.89 Target Zone: $1.24 – $1.51 Potential Upside: 62% ROI Time to Expiration: 178 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
buyandsold
buyandsold Mar. 23 at 1:50 PM
$PRTA truly an unloved stock. If management is not using all its buyback allocation at these sub $9 levels its criminal. They have literally nothing else to do than get this right. Increase my holding by 50% at market open. It is still only 2/3 of what I owned in the past, and is now 2nd biggest holding after $SRPT
0 · Reply
takingstock73
takingstock73 Mar. 23 at 12:49 PM
$PRTA nice reiterate today
1 · Reply
SKVT
SKVT Mar. 17 at 5:56 AM
$RHHBY roche will make a big announcement in AD/PD 2026. Prasinezumab trial 3 will be a game changer in parkinson's disease. $PRTA
2 · Reply
SKVT
SKVT Mar. 17 at 5:54 AM
$PRTA ROCHE will make a big announcement in ADPD2026. Prasinezumab will be a big thing!!
0 · Reply
Itinerant
Itinerant Mar. 6 at 7:34 PM
$PRTA I am newly looking at this company. I do not understand why it has such a large market cap. It seems over valued to me. Perhaps it is just that it has two BP partners. However, there are other players in Parkinson's so that does not particularly impress me unless there is tech that I do not understand. Please give me some constructive input.
2 · Reply
buyandsold
buyandsold Mar. 4 at 10:02 PM
$PRTA actively holding. Does that make me watching part 3?
1 · Reply
takingstock73
takingstock73 Mar. 4 at 7:58 PM
$PRTA watching too
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Feb. 27 at 9:29 PM
$PRTA watching.....
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 11:05 AM
$PRTA RSI: 55.22, MACD: -0.1156 Vol: 0.40, MA20: 9.06, MA50: 9.32 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply